{"id":"https://openalex.org/W4311297250","doi":"https://doi.org/10.1101/2022.12.01.22281309","title":"Personalised medicine for Crohn\u2019s disease is a cost-effective strategy","display_name":"Personalised medicine for Crohn\u2019s disease is a cost-effective strategy","publication_year":2022,"publication_date":"2022-12-03","ids":{"openalex":"https://openalex.org/W4311297250","doi":"https://doi.org/10.1101/2022.12.01.22281309"},"language":"en","primary_location":{"id":"doi:10.1101/2022.12.01.22281309","doi":"https://doi.org/10.1101/2022.12.01.22281309","is_oa":true,"landing_page_url":"https://doi.org/10.1101/2022.12.01.22281309","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2022/12/03/2022.12.01.22281309.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.medrxiv.org/content/medrxiv/early/2022/12/03/2022.12.01.22281309.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063849382","display_name":"Vanessa Buchanan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Vanessa Buchanan","raw_affiliation_strings":["Cogentia Healthcare Consulting, 22 Station Road, Cambridge, CB1 2DB,UK","Cogentia Healthcare Consulting, 22 Station Road, Cambridge, CB 2DB,UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cogentia Healthcare Consulting, 22 Station Road, Cambridge, CB1 2DB,UK","institution_ids":[]},{"raw_affiliation_string":"Cogentia Healthcare Consulting, 22 Station Road, Cambridge, CB 2DB,UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004026303","display_name":"Susan C. Griffin","orcid":"https://orcid.org/0000-0003-2188-8400","observed_orcids":["https://orcid.org/0000-0003-2188-8400"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susan Griffin","raw_affiliation_strings":["Cogentia Healthcare Consulting, 22 Station Road, Cambridge, CB1 2DB,UK","Cogentia Healthcare Consulting, 22 Station Road, Cambridge, CB 2DB,UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cogentia Healthcare Consulting, 22 Station Road, Cambridge, CB1 2DB,UK","institution_ids":[]},{"raw_affiliation_string":"Cogentia Healthcare Consulting, 22 Station Road, Cambridge, CB 2DB,UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024743709","display_name":"Warda Tahir","orcid":"https://orcid.org/0000-0003-0370-6343","observed_orcids":["https://orcid.org/0000-0003-0370-6343"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Warda Tahir","raw_affiliation_strings":["Cogentia Healthcare Consulting, 22 Station Road, Cambridge, CB1 2DB,UK","Cogentia Healthcare Consulting, 22 Station Road, Cambridge, CB 2DB,UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cogentia Healthcare Consulting, 22 Station Road, Cambridge, CB1 2DB,UK","institution_ids":[]},{"raw_affiliation_string":"Cogentia Healthcare Consulting, 22 Station Road, Cambridge, CB 2DB,UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072528165","display_name":"Karen Hills","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129479","display_name":"PredictImmune","ror":"https://ror.org/02nkjx490","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210129479"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Karen Hills","raw_affiliation_strings":["PredictImmune Ltd, Maia Building 260, Babraham Research Campus, Cambridge, CB22 3AT, UK","PredictImmune Ltd, Maia Building 60, Babraham Research Campus, Cambridge, CB 3AT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PredictImmune Ltd, Maia Building 260, Babraham Research Campus, Cambridge, CB22 3AT, UK","institution_ids":["https://openalex.org/I4210129479"]},{"raw_affiliation_string":"PredictImmune Ltd, Maia Building 60, Babraham Research Campus, Cambridge, CB 3AT, UK","institution_ids":["https://openalex.org/I4210129479"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066218040","display_name":"Miles Parkes","orcid":"https://orcid.org/0000-0002-6467-0631","observed_orcids":["https://orcid.org/0000-0002-6467-0631"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Miles Parkes","raw_affiliation_strings":["Babraham Research Campus , Cambridge , CB22 3AT , UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Babraham Research Campus , Cambridge , CB22 3AT , UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001067070","display_name":"Kenneth G. C. Smith","orcid":"https://orcid.org/0000-0003-3829-4326","observed_orcids":["https://orcid.org/0000-0003-3829-4326","https://orcid.org/0000-0001-9170-5775"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]},{"id":"https://openalex.org/I2802466933","display_name":"Cambridge University Hospitals NHS Foundation Trust","ror":"https://ror.org/04v54gj93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933"]},{"id":"https://openalex.org/I4210129479","display_name":"PredictImmune","ror":"https://ror.org/02nkjx490","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210129479"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kenneth GC Smith","raw_affiliation_strings":["Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK, CB2 0AW","Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK","Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK, CB2 2QQ","PredictImmune Ltd, Maia Building 260, Babraham Research Campus, Cambridge, CB22 3AT, UK","PredictImmune Ltd, Maia Building 60, Babraham Research Campus, Cambridge, CB 3AT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK, CB2 0AW","institution_ids":["https://openalex.org/I241749"]},{"raw_affiliation_string":"Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK","institution_ids":["https://openalex.org/I2802466933"]},{"raw_affiliation_string":"Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK, CB2 2QQ","institution_ids":["https://openalex.org/I241749"]},{"raw_affiliation_string":"PredictImmune Ltd, Maia Building 260, Babraham Research Campus, Cambridge, CB22 3AT, UK","institution_ids":["https://openalex.org/I4210129479"]},{"raw_affiliation_string":"PredictImmune Ltd, Maia Building 60, Babraham Research Campus, Cambridge, CB 3AT, UK","institution_ids":["https://openalex.org/I4210129479"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047269468","display_name":"Paul Lyons","orcid":"https://orcid.org/0000-0001-7035-8997","observed_orcids":["https://orcid.org/0000-0001-7035-8997"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]},{"id":"https://openalex.org/I4210129479","display_name":"PredictImmune","ror":"https://ror.org/02nkjx490","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210129479"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paul A Lyons","raw_affiliation_strings":["Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK, CB2 0AW","Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK, CB2 2QQ","PredictImmune Ltd, Maia Building 260, Babraham Research Campus, Cambridge, CB22 3AT, UK","PredictImmune Ltd, Maia Building 60, Babraham Research Campus, Cambridge, CB 3AT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK, CB2 0AW","institution_ids":["https://openalex.org/I241749"]},{"raw_affiliation_string":"Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK, CB2 2QQ","institution_ids":["https://openalex.org/I241749"]},{"raw_affiliation_string":"PredictImmune Ltd, Maia Building 260, Babraham Research Campus, Cambridge, CB22 3AT, UK","institution_ids":["https://openalex.org/I4210129479"]},{"raw_affiliation_string":"PredictImmune Ltd, Maia Building 60, Babraham Research Campus, Cambridge, CB 3AT, UK","institution_ids":["https://openalex.org/I4210129479"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100666789","display_name":"James Christopher Lee","orcid":"https://orcid.org/0000-0001-5711-9385","observed_orcids":["https://orcid.org/0000-0001-5711-9385"]},"institutions":[{"id":"https://openalex.org/I2801081054","display_name":"The Francis Crick Institute","ror":"https://ror.org/04tnbqb63","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801081054"]},{"id":"https://openalex.org/I2801138448","display_name":"The Royal Free Hospital","ror":"https://ror.org/01ge67z96","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I169248724","https://openalex.org/I2801138448"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"James C Lee","raw_affiliation_strings":["Royal Free Hospital, Pond St, London, UK, NW3 2QG","The Francis Crick Institute, 1 Midland Road, London, UK, NW1 1AT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Free Hospital, Pond St, London, UK, NW3 2QG","institution_ids":["https://openalex.org/I2801138448"]},{"raw_affiliation_string":"The Francis Crick Institute, 1 Midland Road, London, UK, NW1 1AT","institution_ids":["https://openalex.org/I2801081054"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026620118","display_name":"Eoin F. McKinney","orcid":"https://orcid.org/0000-0003-3516-3072","observed_orcids":["https://orcid.org/0000-0003-3516-3072"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]},{"id":"https://openalex.org/I2802466933","display_name":"Cambridge University Hospitals NHS Foundation Trust","ror":"https://ror.org/04v54gj93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933"]},{"id":"https://openalex.org/I4210129479","display_name":"PredictImmune","ror":"https://ror.org/02nkjx490","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210129479"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Eoin F McKinney","raw_affiliation_strings":["Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK, CB2 0AW","Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK","Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK, CB2 2QQ","PredictImmune Ltd, Maia Building 260, Babraham Research Campus, Cambridge, CB22 3AT, UK","PredictImmune Ltd, Maia Building 60, Babraham Research Campus, Cambridge, CB 3AT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK, CB2 0AW","institution_ids":["https://openalex.org/I241749"]},{"raw_affiliation_string":"Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK","institution_ids":["https://openalex.org/I2802466933"]},{"raw_affiliation_string":"Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK, CB2 2QQ","institution_ids":["https://openalex.org/I241749"]},{"raw_affiliation_string":"PredictImmune Ltd, Maia Building 260, Babraham Research Campus, Cambridge, CB22 3AT, UK","institution_ids":["https://openalex.org/I4210129479"]},{"raw_affiliation_string":"PredictImmune Ltd, Maia Building 60, Babraham Research Campus, Cambridge, CB 3AT, UK","institution_ids":["https://openalex.org/I4210129479"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5063849382"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.021199999377131462,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/crohn-s-disease","display_name":"Crohn's disease","score":1.0},{"id":"https://openalex.org/keywords/personalized-medicine","display_name":"personalized medicine","score":0.968999981880188},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9150000214576721},{"id":"https://openalex.org/keywords/anti-tnf-therapy","display_name":"anti-TNF therapy","score":0.9279999732971191},{"id":"https://openalex.org/keywords/top-down-therapy","display_name":"top-down therapy","score":0.7609999775886536},{"id":"https://openalex.org/keywords/step-up-therapy","display_name":"step-up therapy","score":0.8339999914169312},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.9670000076293945},{"id":"https://openalex.org/keywords/risk-of-relapse","display_name":"relapse risk","score":0.6909999847412109},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.9269999861717224},{"id":"https://openalex.org/keywords/inflammatory-bowel-disease","display_name":"inflammatory bowel disease","score":0.8870000243186951},{"id":"https://openalex.org/keywords/hospitalization-costs","display_name":"hospital costs","score":0.6970000267028809}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8045082092285156},{"id":"https://openalex.org/C64332521","wikidata":"https://www.wikidata.org/wiki/Q614165","display_name":"Quality-adjusted life year","level":3,"score":0.6725923418998718},{"id":"https://openalex.org/C2779280984","wikidata":"https://www.wikidata.org/wiki/Q1472","display_name":"Crohn's disease","level":3,"score":0.5906445384025574},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.5477149486541748},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5466318130493164},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5176439881324768},{"id":"https://openalex.org/C2779256446","wikidata":"https://www.wikidata.org/wiki/Q33959","display_name":"Nice","level":2,"score":0.48625409603118896},{"id":"https://openalex.org/C127454912","wikidata":"https://www.wikidata.org/wiki/Q942582","display_name":"Cost\u2013benefit analysis","level":2,"score":0.41507017612457275},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.38639190793037415},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2756323218345642},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.12036111950874329},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0953705906867981},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1101/2022.12.01.22281309","doi":"https://doi.org/10.1101/2022.12.01.22281309","is_oa":true,"landing_page_url":"https://doi.org/10.1101/2022.12.01.22281309","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2022/12/03/2022.12.01.22281309.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1101/2022.12.01.22281309","doi":"https://doi.org/10.1101/2022.12.01.22281309","is_oa":true,"landing_page_url":"https://doi.org/10.1101/2022.12.01.22281309","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2022/12/03/2022.12.01.22281309.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4311297250.pdf","grobid_xml":"https://content.openalex.org/works/W4311297250.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W1562415841","https://openalex.org/W1595046345","https://openalex.org/W2015008025","https://openalex.org/W2020634002","https://openalex.org/W2048755819","https://openalex.org/W2056586250","https://openalex.org/W2102987799","https://openalex.org/W2103056503","https://openalex.org/W2122317738","https://openalex.org/W2126807394","https://openalex.org/W2130577180","https://openalex.org/W2145436896","https://openalex.org/W2152381563","https://openalex.org/W2155355043","https://openalex.org/W2208479446","https://openalex.org/W2282998591","https://openalex.org/W2309207579","https://openalex.org/W2514071779","https://openalex.org/W2794388065","https://openalex.org/W2795997624","https://openalex.org/W2883422525","https://openalex.org/W2903531770","https://openalex.org/W2942200926","https://openalex.org/W3012775556","https://openalex.org/W4233817719"],"related_works":["https://openalex.org/W2999696085","https://openalex.org/W3122149371","https://openalex.org/W4406699440","https://openalex.org/W4415507164","https://openalex.org/W2139527007","https://openalex.org/W4213380669","https://openalex.org/W2906303348","https://openalex.org/W4394590212","https://openalex.org/W4251097246","https://openalex.org/W2014298657"],"abstract_inverted_index":{"ABSTRACT":[0],"Objective":[1],"To":[2],"evaluate":[3],"the":[4,15,113,151,198,233,260,267,295,301,318],"cost-effectiveness":[5,131,153],"of":[6,25,43,49,71,88,101,115,134,155,191,219,230,262,288,297,320,328,337,341,356,367,372,383],"a":[7,35,61,75,98,188,227,289,293,332,342,380],"personalised":[8,62,120,203,326,347],"medicine":[9,63,204,348],"strategy":[10,64,205],"for":[11,335,349],"Crohn\u2019s":[12,104,212,276,338,350],"disease":[13,105,181,213,277,351],"in":[14,65,97,128,176,211,232,266,300,353],"UK,":[16],"using":[17,74,206],"early":[18,282],"targeted":[19],"top-down":[20],"therapy":[21,51,126,208,285],"compared":[22],"to":[23,111,165,214,225,324,345],"standard":[24,48],"care.":[26],"Materials":[27],"&":[28],"Methods":[29],"A":[30,202],"decision":[31],"tree":[32],"leading":[33],"into":[34],"Markov":[36],"state-transition":[37],"model":[38,85,112],"was":[39],"constructed,":[40],"allowing":[41],"comparison":[42,87],"two":[44],"treatment":[45,81,121,330,336],"approaches:":[46],"1)":[47],"care":[50],"following":[52],"established":[53],"UK":[54,234,268,302],"clinical":[55],"guidelines":[56],"(\u2018step-up\u2019":[57],"treatment)":[58],"and":[59,91,145,158,174,183,369],"2)":[60],"which":[66,273],"patients":[67,106,215,253,274,299],"identified":[68],"as":[69,286],"high-risk":[70],"subsequent":[72,220],"relapse":[73,221],"prognostic":[76,247,343],"biomarker":[77],"receive":[78],"\u2018top-down\u2019":[79,290],"anti-TNF":[80,123,207,283],"at":[82,209,216,259,322],"diagnosis.":[83],"The":[84,358,374],"facilitated":[86],"both":[89],"costs":[90,144,163,177],"Quality":[92],"Adjusted":[93],"Life":[94],"Years":[95],"(QALYs)":[96],"hypothetical":[99],"cohort":[100],"newly":[102],"diagnosed":[103],"with":[107,122,141,275,281,306,363],"sensitivity":[108,384],"analyses":[109,385],"undertaken":[110],"impact":[114,196],"key":[116],"assumptions.":[117],"Results":[118],"Early":[119],"based":[124,254,284],"combination":[125],"resulted":[127],"an":[129,307,364,370],"incremental":[130,143,147,172,365],"ratio":[132],"(ICER)":[133],"\u00a32,176":[135],"per":[136,160],"quality-adjusted":[137],"life":[138],"year":[139],"(QALY),":[140],"\u00a3717":[142,368],"0.330":[146,357],"QALYs,":[148],"substantially":[149],"below":[150],"NICE":[152],"threshold":[154],"between":[156],"\u00a320,000":[157],"\u00a330,000":[159],"QALY.":[161],"Additional":[162],"relating":[164],"earlier":[166],"biologic":[167],"use":[168,229,319,327],"were":[169,377],"offset":[170],"by":[171,179,379],"QALYS":[173],"reductions":[175],"driven":[178],"fewer":[180],"flares":[182],"hospitalisations.":[184],"Sensitivity":[185],"analysis":[186],"across":[187],"wide":[189,381],"range":[190,382],"parameter":[192],"assumptions":[193],"did":[194],"not":[195],"on":[197,255],"model\u2019s":[199,375],"conclusion.":[200],"Conclusion":[201],"diagnosis":[210,263,323],"high":[217],"risk":[218],"is":[222,331,360],"highly":[223],"likely":[224],"be":[226,279],"cost-effective":[228,333],"resources":[231],"National":[235],"Health":[236],"Service.":[237],"KEY":[238],"SUMMARY":[239],"Established":[240],"Knowledge":[241],"Currently":[242],"there":[243],"are":[244,303],"no":[245],"validated":[246],"test":[248,344],"that":[249,317],"can":[250],"stratify":[251],"IBD":[252,298],"long":[256],"term":[257],"outcomes":[258],"point":[261],"used":[264],"routinely":[265],"It":[269],"therefore":[270],"remains":[271],"unclear":[272],"should":[278],"treated":[280,305],"part":[287],"regimen.":[291],"As":[292],"consequence,":[294],"majority":[296],"currently":[304],"accelerated":[308],"step-up":[309],"approach":[310,334,359],"Significant":[311],"new":[312],"findings":[313],"We":[314],"show":[315],"here":[316],"biomarkers":[321],"guide":[325],"such":[329],"disease.":[339],"Use":[340],"deliver":[346],"results":[352],"positive":[354],"QALY":[355],"cost":[361,366],"effective":[362],"ICER":[371],"2,176":[373],"conclusions":[376],"unaffected":[378]},"counts_by_year":[{"year":2025,"cited_by_count":2}],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2022-12-25T00:00:00"}